黛安瑟思治疗公司（NASDAQ:DNTH）报告季度亏损每股$(0.81)，优于分析师一致预期的$(0.85)，超出4.71%。这比去年同期每股$(0.71)的亏损扩大了14.08%。公司报告季度销售额为132万美元，超出分析师一致预期的85.97万美元，超出54.12%。这比去年同期的45.7万美元增长了189.93%。

以上内容来自Benzinga Earnings专栏，原文如下：

Dianthus Therapeutics (NASDAQ:DNTH) reported quarterly losses of $(0.81) per share which beat the analyst consensus estimate of $(0.85) by 4.71 percent. This is a 14.08 percent decrease over losses of $(0.71) per share from the same period last year. The company reported quarterly sales of $1.32 million which beat the analyst consensus estimate of $859.70 thousand by 54.12 percent. This is a 189.93 percent increase over sales of $457.00 thousand the same period last year.